Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation

Thorax

Volumn 58, Issue 12, 2003, Pages 1042-1047

  Salome, C M ^a,b   Leuppi, J D ^b   Freed, R ^c   Marks, G B ^b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MANNITOL; NITRIC OXIDE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INHALATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SPUTUM ANALYSIS;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHITIS; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PERCEPTION; SPUTUM;

EID: 0348012896     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.12.1042     Document Type: Article

References (26)

1. Salome CM, Reddel HK, Ware SI, et al. Effect of budesonide on the perception of induced airway aarrowing in subjects with asthma. Am J Respir Crit Care Med 2002;165:15-21.
2. Chetta A, Gerra G, Foresi A, et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med 1998;157:116-22.
3. In't Veen JCCM, Smits HH, Ravensberg AJJ, et al. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 1998;158:1134-41.
4. Turcotte H, Boulet L-P. Perception of breathlessness during early and late asthmatic reponses. Am Rev Respir Dis 1993;148:514-8.
5. Wilson RC, Jones PW. Influence of prior ventilatory experience on the estimation of breathlessness during exercise. Clin Sci 1990;78:149-53.
6. Wilson RC, Oldfield WLG, Jones PW. Effect of residence at altitude on the perception of breathlessness on return to sea level in normal subjects. Clin Sci 1993;84:159-67.
7. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose-reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001;163:406-12.
8. Gibson PG, Wlodarczyk J, Hensley MJ, et al. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med 1995;123:488-92.
9. In't Veen JCCM, Smits HH, Hiemstra PS, et al. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999;160:93-9.
10. Reddel HK, Jenkins CR, Marks GB, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 2000;16:226-35.
11. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
12. Anderson SD, Brannan J, Spring J, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997;156:758-65.
13. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142:1009-14.
14. Bijl-Hofland ID, Cloosterman SGM, Folgering HTM, et al. Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients. Eur Respir J 1999;13:955-60.
15. James AL, Carroll N, De Klerk N, et al. Increased perception of airway narrowing in patients with mild asthma. Respirology 1998;3:241-5.
16. Marks GBM, Yates DH, Sist M, et al. Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate. Thorax 1996;51:793-8.
17. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800-3.
18. Salome CM, Roberts AM, Brown NJ, et al. Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med 1999;159:911-6.
19. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
20. Gibson PG, Wong BJO, Hepperle MJE, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992;22:525-32.
21. Burdon JGW, Juniper EF, Killian KJ, et al. The perception of breathlessness in asthma. Am Rev Respir Dis 1982;126:825-8.
22. Bijl-Hofland ID, Cloosterman SG, Folgering HT, et al. Relation of the perception of airway obstruction to the severity of asthma. Thorax 1999;54:15-9.
23. Roisman GL, Peiffer C, Lacronique JG, et al. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 1995;96:12-21.
24. Bijl-Hofland ID, Folgering HTM, van den Hoogen H, et al. Perception of bronchoconstriction in asthma patients measured during histamine challenge test. Eur Respir J 1999;14:1049-54.
25. Boulet L-P, Leblanc P, Turcotte H. Perception scoring of induced bronchoconstriction as an index of awareness of asthma symptoms. Chest 1994;105:1430-3.
26. 2-agonists, improve the perception of bronchoconstriction in asthma. Am J Respir Crit Care Med 2001;164:764-9.